RIVA, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.264
EU - Europa 6.177
AS - Asia 5.242
SA - Sud America 646
Continente sconosciuto - Info sul continente non disponibili 235
AF - Africa 133
OC - Oceania 5
Totale 26.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.920
GB - Regno Unito 1.849
IT - Italia 1.411
SG - Singapore 1.395
CN - Cina 1.329
HK - Hong Kong 764
SE - Svezia 631
VN - Vietnam 567
BR - Brasile 473
DE - Germania 438
FI - Finlandia 345
NL - Olanda 329
BD - Bangladesh 324
RU - Federazione Russa 304
FR - Francia 251
UA - Ucraina 239
TR - Turchia 199
CA - Canada 168
IN - India 136
KR - Corea 106
BG - Bulgaria 94
ID - Indonesia 71
MX - Messico 54
AR - Argentina 53
IQ - Iraq 46
BE - Belgio 40
JP - Giappone 38
CZ - Repubblica Ceca 31
PL - Polonia 31
ZA - Sudafrica 30
ES - Italia 29
IL - Israele 29
IE - Irlanda 26
CO - Colombia 25
UZ - Uzbekistan 25
AE - Emirati Arabi Uniti 24
IR - Iran 23
PK - Pakistan 23
AT - Austria 22
CL - Cile 22
EC - Ecuador 21
LT - Lituania 20
MA - Marocco 20
SC - Seychelles 20
CR - Costa Rica 19
VE - Venezuela 18
MY - Malesia 17
KE - Kenya 16
BZ - Belize 15
PH - Filippine 15
AZ - Azerbaigian 14
PY - Paraguay 14
EG - Egitto 13
JM - Giamaica 13
EU - Europa 11
HN - Honduras 11
TN - Tunisia 11
TT - Trinidad e Tobago 11
RO - Romania 10
SA - Arabia Saudita 10
SV - El Salvador 10
TW - Taiwan 10
CY - Cipro 9
DK - Danimarca 9
GT - Guatemala 9
NP - Nepal 9
SK - Slovacchia (Repubblica Slovacca) 9
CH - Svizzera 8
GP - Guadalupe 8
RS - Serbia 8
TH - Thailandia 8
AL - Albania 7
DZ - Algeria 7
GR - Grecia 7
JO - Giordania 7
NI - Nicaragua 7
PE - Perù 7
PR - Porto Rico 7
PS - Palestinian Territory 7
BO - Bolivia 6
BY - Bielorussia 6
EE - Estonia 6
OM - Oman 6
UY - Uruguay 6
CW - ???statistics.table.value.countryCode.CW??? 5
KG - Kirghizistan 5
AM - Armenia 4
AU - Australia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
BH - Bahrain 3
KZ - Kazakistan 3
LB - Libano 3
PA - Panama 3
PT - Portogallo 3
QA - Qatar 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
Totale 26.450
Salva come PNG Salva come JPEG
Città #
Ashburn 1.729
Southend 1.357
Fairfield 1.240
Santa Clara 1.063
Singapore 884
Woodbridge 804
Hong Kong 751
Chandler 638
San Jose 606
Houston 588
Ann Arbor 507
Seattle 479
Jacksonville 428
Wilmington 426
Dearborn 423
Council Bluffs 399
Cambridge 391
Nyköping 350
Hefei 331
Beijing 294
Amsterdam 252
New York 243
Helsinki 241
London 232
Modena 206
Los Angeles 200
Ho Chi Minh City 186
Chicago 179
Milan 139
The Dalles 129
Hanoi 126
Izmir 105
San Diego 105
Seoul 102
Munich 93
Princeton 90
Sofia 90
Buffalo 88
Eugene 82
Boardman 77
Fremont 75
Moscow 73
Lauterbourg 71
Rome 70
Columbus 64
Dallas 64
Bremen 55
Shanghai 52
Orem 51
São Paulo 51
Jakarta 46
Bologna 44
Salt Lake City 43
Des Moines 42
Frankfurt am Main 37
Toronto 36
Atlanta 33
Brussels 33
Naples 32
Tokyo 32
Redwood City 31
Da Nang 29
North Bergen 28
Ottawa 28
Boston 27
Montreal 27
Washington 25
Chennai 24
Turku 24
Paris 23
Tashkent 23
Brooklyn 22
Haiphong 22
Phoenix 22
San Francisco 22
Warsaw 22
Denver 21
Tampa 21
Dublin 20
Elk Grove Village 19
Las Vegas 19
Philadelphia 19
Detroit 17
Mexico City 17
Guangzhou 16
Johannesburg 16
Palermo 16
Reggio Emilia 16
Rio de Janeiro 16
Stockholm 16
Albuquerque 15
Belize City 15
Miano 15
Nairobi 15
Turin 15
Baghdad 14
Kunming 14
Miami 14
San José 14
Charlotte 13
Totale 18.449
Salva come PNG Salva come JPEG
Nome #
B cells and herpesviruses: a model of lymphoproliferation 491
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 466
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 461
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 451
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 425
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 416
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 408
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 400
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 399
Mucorales-specific T cells in patients with hematologic malignancies 394
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 394
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 390
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 388
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 382
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 378
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 377
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 375
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 374
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 372
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 371
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 368
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 364
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 363
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 363
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 359
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 358
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 357
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 343
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 334
Parvoviruses in blood donors and transplant patients, Italy 331
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 331
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 329
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 328
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 328
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 328
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 327
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 320
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 319
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 318
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 309
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 305
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 304
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 303
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 302
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 301
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 299
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 298
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 297
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 296
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 295
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 286
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 286
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 284
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 284
How I treat HHV8/KSHV-related diseases in posttransplant patients. 281
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 280
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 279
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 273
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 270
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 267
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 266
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 253
Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide 253
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 252
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 247
Cytomegalovirus and ClostridiumDifficile co-infection in severe ulcero-hemorrhagic colitis during inductionchemotherapy for acute lymphoblastic leukemia 239
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 238
Successful generation of p190-BCR ABL-specific T-cell lines for prophylaxis/treatment of minimal residual disease in HSCT recipients with Ph+ acute lymphoblastic leukaemia 231
Pneumonia in acute leukaemia:blossoming culprits 225
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 225
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 219
Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study 217
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 217
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 213
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 212
Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells 212
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 207
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 203
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 200
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 193
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 190
Linking COVID-19, monocyte activation and sepsis: MDW, a novel biomarker from cytometry 190
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 187
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 173
Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias. 170
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 168
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 153
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 141
The dynamic functions of IRF4 in B cell malignancies 129
Totale 26.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.913
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.133 0 0 0 0 29 63 104 92 175 135 338 197
2022/20231.999 281 248 142 187 281 244 48 184 174 18 105 87
2023/20241.295 41 69 98 96 271 146 137 207 23 24 60 123
2024/20253.847 155 49 76 279 701 541 309 231 431 151 385 539
2025/20267.199 611 367 609 647 969 498 882 332 726 620 540 398
2026/20272.149 180 458 458 855 198 0 0 0 0 0 0 0
Totale 26.702